Skip to main content
placeholder image

56. In vitro and preclinical studies of targeted alpha therapy for human breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2

Journal Article


Abstract


Publication Date


  • 2001

Citation


  • Allen, B. J., Tian, Z., Andronicos, N. M., Rizvi, S., & Ranson, M. (2001). 56. In vitro and preclinical studies of targeted alpha therapy for human breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2. Nuclear Medicine Communications, 22(8), 939-940. doi:10.1097/00006231-200108000-00066

Web Of Science Accession Number


Start Page


  • 939

End Page


  • 940

Volume


  • 22

Issue


  • 8

Abstract


Publication Date


  • 2001

Citation


  • Allen, B. J., Tian, Z., Andronicos, N. M., Rizvi, S., & Ranson, M. (2001). 56. In vitro and preclinical studies of targeted alpha therapy for human breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2. Nuclear Medicine Communications, 22(8), 939-940. doi:10.1097/00006231-200108000-00066

Web Of Science Accession Number


Start Page


  • 939

End Page


  • 940

Volume


  • 22

Issue


  • 8